His scientific interests lie mostly in Internal medicine, Kidney disease, Renal function, Creatinine and Endocrinology. His Internal medicine research includes elements of Surgery and Cardiology. His studies in Kidney disease integrate themes in fields like Diabetes mellitus, Nephrology, End stage renal disease and Intensive care medicine.
Michael G. Shlipak studies Renal function, namely Cystatin C. He has included themes like Genome-wide association study, Cohort, Pathology, Urinary system and Biomarker in his Creatinine study. The Endocrinology study combines topics in areas such as Gastroenterology, Lipodystrophy and Meta-analysis.
His primary scientific interests are in Internal medicine, Renal function, Kidney disease, Endocrinology and Creatinine. The concepts of his Internal medicine study are interwoven with issues in Diabetes mellitus and Cardiology. He is involved in the study of Renal function that focuses on Cystatin C in particular.
As a member of one scientific family, Michael G. Shlipak mostly works in the field of Kidney disease, focusing on Cohort study and, on occasion, Intensive care medicine. His Endocrinology research is multidisciplinary, incorporating elements of Fibroblast growth factor 23, Case-control study and C-reactive protein. Michael G. Shlipak combines subjects such as Acute kidney injury, Urine, Urinary system and Pathology with his study of Creatinine.
Michael G. Shlipak mostly deals with Internal medicine, Kidney disease, Renal function, Albuminuria and Creatinine. Internal medicine and Cardiology are frequently intertwined in his study. His study looks at the intersection of Kidney disease and topics like Urine with Albumin.
His research in Renal function is mostly focused on Cystatin C. His Albuminuria research includes themes of Nephrology and Intensive care medicine. His Creatinine research incorporates themes from Gastroenterology and End stage renal disease.
Michael G. Shlipak mainly investigates Renal function, Kidney disease, Internal medicine, Albuminuria and Biomarker. He has researched Renal function in several fields, including Urology, Urine, Tamm–Horsfall protein, Proportional hazards model and Hazard ratio. His studies deal with areas such as Diabetes mellitus, Blood pressure, Urinary system, Creatinine and Prospective cohort study as well as Kidney disease.
Cystatin C is the focus of his Creatinine research. The various areas that Michael G. Shlipak examines in his Internal medicine study include Gastroenterology and Cardiology. His research in Albuminuria intersects with topics in Psychological intervention, Socioeconomic status, Intervention and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
Kunihiro Matsushita;Marije van der Velde;Brad C. Astor;Mark Woodward.
The Lancet (2010)
Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease
A Levin;PE Stevens;RW Bilous;J Coresh.
Kidney International (2013)
Cystatin C and the risk of death and cardiovascular events among elderly persons.
Michael G. Shlipak;Mark J. Sarnak;Ronit Katz;Linda F. Fried.
The New England Journal of Medicine (2005)
Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysis
Steven G. Coca;Bushra Yusuf;Bushra Yusuf;Michael G. Shlipak;Michael G. Shlipak;Amit X. Garg.
American Journal of Kidney Diseases (2009)
Renal Impairment and Outcomes in Heart Failure: Systematic Review and Meta-Analysis
Grace L. Smith;Judith H. Lichtman;Michael B. Bracken;Michael G. Shlipak;Michael G. Shlipak.
Journal of the American College of Cardiology (2006)
Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency
Michael G. Shlipak;Linda F. Fried;Casey Crump;Anthony J. Bleyer.
Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain.
John G. Canto;Michael G. Shlipak;William J. Rogers;Judith A. Malmgren.
Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
Jacqueline Neuhaus;David R. Jacobs;Jason V. Baker;Jason V. Baker;Alexandra Calmy.
The Journal of Infectious Diseases (2010)
Cardiovascular Mortality Risk in Chronic Kidney Disease: Comparison of Traditional and Novel Risk Factors
Michael G. Shlipak;Linda F. Fried;Mary Cushman;Teri A. Manolio.
New loci associated with kidney function and chronic kidney disease
Anna Köttgen;Anna Köttgen;Cristian Pattaro;Carsten A. Böger;Christian Fuchsberger.
Nature Genetics (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: